These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Tolentino MJ; Miller JW; Gragoudas ES; Jakobiec FA; Flynn E; Chatzistefanou K; Ferrara N; Adamis AP Ophthalmology; 1996 Nov; 103(11):1820-8. PubMed ID: 8942877 [TBL] [Abstract][Full Text] [Related]
3. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975 [TBL] [Abstract][Full Text] [Related]
4. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165 [TBL] [Abstract][Full Text] [Related]
5. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Ameri H; Chader GJ; Kim JG; Sadda SR; Rao NA; Humayun MS Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5708-15. PubMed ID: 18055823 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391 [TBL] [Abstract][Full Text] [Related]
7. One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy. Lobo CL; Bernardes RC; de Abreu JR; Cunha-Vaz JG Arch Ophthalmol; 2001 Oct; 119(10):1469-74. PubMed ID: 11594946 [TBL] [Abstract][Full Text] [Related]
8. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Hofman P; van Blijswijk BC; Gaillard PJ; Vrensen GF; Schlingemann RO Arch Ophthalmol; 2001 Jun; 119(6):861-6. PubMed ID: 11405837 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369 [TBL] [Abstract][Full Text] [Related]
11. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516 [TBL] [Abstract][Full Text] [Related]
12. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Li W; Yanoff M; Liu X; Ye X Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318 [TBL] [Abstract][Full Text] [Related]
13. Aflibercept Action in a Rabbit Model of Chronic Retinal Neovascularization: Reversible Inhibition of Pathologic Leakage With Dose-Dependent Duration. Cao J; MacPherson TC; Iglesias BV; Liu Y; Tirko N; Yancopoulos GD; Wiegand SJ; Romano C Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1033-1044. PubMed ID: 29450547 [TBL] [Abstract][Full Text] [Related]
14. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. Kumar Gupta S; Kumar B; Srinivasan BP; Nag TC; Srivastava S; Saxena R; Aggarwal A J Ocul Pharmacol Ther; 2013 May; 29(4):419-26. PubMed ID: 23215831 [TBL] [Abstract][Full Text] [Related]
15. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. Robison WG; Jacot JL; Katz ML; Glover JP J Ocul Pharmacol Ther; 2000 Apr; 16(2):109-20. PubMed ID: 10803422 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951 [TBL] [Abstract][Full Text] [Related]
17. Evolution of morphologic changes after intravitreous injection of gentamicin. Hines J; Vinores SA; Campochiaro PA Curr Eye Res; 1993 Jun; 12(6):521-9. PubMed ID: 8359028 [TBL] [Abstract][Full Text] [Related]
18. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous. Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Lobo CL; Bernardes RC; Cunha-Vaz JG Arch Ophthalmol; 2000 Oct; 118(10):1364-9. PubMed ID: 11030818 [TBL] [Abstract][Full Text] [Related]
20. Type a syndrome of insulin resistance: anterior chamber anomalies of the eye and effects of insulin-like growth factor-I on the retina. Martin XD; Zenobi PD Ophthalmologica; 2001; 215(2):117-23. PubMed ID: 11244342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]